Showing results (61-70 of 131) with videos related to

Sort By:
Pageof 14
Biomedicines|May 27, 2023
Impact of Angiogenic and Cardiovascular Biomarkers for Prediction of Placental Dysfunction in the First Trimester of PregnancyMadalina Nicoleta Nan, Álvaro García-Osuna, Josefina Mora, et al.
Journal of Lipid Research|January 17, 2002
ApoA-I(MALLORCA) impairs LCAT activation and induces dominant familial hypoalphalipoproteinemiaJesús M Martín-Campos, Josep Julve, Joan Carles Escolà, et al.
Clinica E Investigacion En Arteriosclerosis : Publicacion Oficial De La Sociedad Espanola De Arteriosclerosis|August 14, 2013
[Alterations in the protein content and dysfunction of high-density lipoproteins from hyperhomocysteinemic mice]Josep Julve, Teresa Laura Errico, Xiangyu Chen, et al.
Translational Research : the Journal of Laboratory and Clinical Medicine|November 14, 2012
Resveratrol administration or SIRT1 overexpression does not increase LXR signaling and macrophage-to-feces reverse cholesterol transport in vivoJoan Carles Escolà-Gil, Josep Julve, Gemma Llaverias, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|January 8, 2011
Mast cell activation in vivo impairs the macrophage reverse cholesterol transport pathway in the mouseMiriam Lee-Rueckert, Reija Silvennoinen, Noemi Rotllan, et al.
European Journal of Human Genetics : EJHG|June 19, 2008
Genome-wide linkage analysis for identifying quantitative trait loci involved in the regulation of lipoprotein a (Lpa) levelsSonia López, Alfonso Buil, Jordi Ordoñez, et al.
Diabetes/Metabolism Research and Reviews|March 14, 2013
Latent autoimmune diabetes in adults is perched between type 1 and type 2: evidence from adults in one region of SpainAngels Mollo, Marta Hernandez, Josep R Marsal, et al.
Biochimica Et Biophysica Acta|October 18, 2005
Paradoxical exacerbation of combined hyperlipidemia in human apolipoprotein A-II transgenic mice treated with fenofibrateVicent Ribas, Xavier Palomer, Núria Roglans, et al.
Pageof 14